Skip to content

Mindfulness IN-home for Diabetes and Sleep Health

Adapting a Mindfulness Intervention to Improve Sleep and Reduce Diabetes Risk Among a Diverse Sample in Atlanta

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04160078
Acronym
MINDS
Enrollment
18
Registered
2019-11-12
Start date
2019-12-18
Completion date
2021-08-29
Last updated
2022-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 2

Keywords

Diabetes, Mindfulness, Public health, Sleep

Brief summary

The study investigates the effects of a mindfulness intervention on sleep and subsequent cardio-metabolic risk in an adult Atlanta population aged 18 and older.

Detailed description

Type 2 diabetes mellitus has been identified as a leading cause of death in the United States. This problem is alarmingly higher in southern state, including Georgia. Sleep, a modifiable health behavior, may be a target for reducing the burden of diabetes. This research study will enroll adults from the community to participate in a mindfulness-based stress reduction program (MBSR) via an app on his/her cellular phone. Participants will also wear a wrist monitor to estimate activity and sleep as well as provide a blood sample before and after the MBSR. Following the 6-week intervention program, participants will provide information via focus groups to obtain feedback on his/her experiences during the program. This pilot study will enroll (N=20) racially diverse men and women who are 18 years and older and reside in Atlanta. Participants will be recruited from the community via advertisements, community events and existing community partnerships. Trained research assistants will screen potential participants. Eligible participants will be contacted via phone and scheduled to attend a baseline visit to collect a blood sample and attend a sleep education session.

Interventions

* 1-hour session on sleep hygiene and 7-week follow up using a mindfulness app, an app that features guided meditation and can be used to assess adherence. * Sleep log diary: self report of sleep records * Wrist Actigraphy, to monitor sleep patterns. Participants will be instructed on wearing the sleep monitor (Spectrum, Philips Respironics, Murrysville, PA) on their non-dominant wrist for the next 7-weeks

Sponsors

Georgia Center for Diabetes Translation Research
CollaboratorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Emory University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Resident in the Atlanta, Georgia area * Proficient in English * Have a smartphone * Sleep quality score \>5 on the validated Pittsburgh Sleep Quality Index * Prediabetes (defined as fasting glucose between 100-125 mg/dL or HbA1c between 5.7-6.4%)

Exclusion criteria

* Pregnant women * Sleep quality score less than a score 5 on the validated Pittsburgh Sleep Quality Index * Refusal to download Mindfulness mobile application * Diagnosis of HIV, AIDS, Liver disease (diagnosed, i.e. chronic or alcoholic hepatitis, cirrhosis), Renal/Kidney disease * Current Cocaine, heroin, or methamphetamines use and/or has a history of treatment for alcohol or drug abuse * Pre-diabetes: defined as a score greater than 3 on the American Diabetes Association 60-Second Type 2 Diabetes Risk Test

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With PSS Score Indicating High StressBaseline, 4 weeks post-interventionThe perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 27 to 40 are categorized as having high stress.
Perceived Stress Scale (PSS)Baseline, 4 weeks post-interventionThe perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress.
Number of Participants With PSS Score Indicating Low StressBaseline, 4 weeks post-interventionThe perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 0 to 13 are categorized as having low stress.
Number of Participants With PSS Score Indicating Moderate StressBaseline, 4 weeks post-interventionThe perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 14 to 26 are categorized as having moderate stress.
Pittsburgh Sleep Quality Index (PSQI) ScoreBaseline, 4 weeks post-interventionGlobal sleep quality was measured via the validated Pittsburgh Sleep Quality Index (PSQI). The PSQI is a self-rated questionnaire which assesses several dimensions of sleep including sleep quality, duration, and disturbances over a 1-month time interval. In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score which ranges from 0 to 21. Poor sleep quality is defined as a global score of 5 or greater.
Sleep DurationBaseline, 4 weeks post-interventionSleep duration was measured in hours and minutes using a sleep 7-day actigraphy (Philips Respironics Actiwatch Spectrum Plus) on the non-dominant wrist, and confirmed with daily sleep logs. Self-reported sleep duration was also measured.

Secondary

MeasureTime frameDescription
Body Mass Index (BMI)Baseline, 4 weeks post-interventionBody mass index (BMI) is calculated as weight in kilograms (kg) divided by the square of the body height measured in meters (m). A BMI between 18.5 and 24.9 is considered to be normal weight. A BMI of 25-29.9 indicates overweight, while a BMI of 30 or more indicates obesity.
Blood PressureBaseline, 4 weeks post-interventionBlood pressure is the pressure of circulating blood on the walls of blood vessels and is measured in millimeters of mercury (mmHg). Three seated blood pressure measurements were made using an electronic sphygmomanometer. An average of the last two readings were used to assess systolic and diastolic blood pressure. Blood pressure values of less than 120 mmHg systolic and 80 mmHg diastolic are considered within the normal range.
WeightBaseline, 4 weeks post-interventionParticipants provided their weight in pounds (lbs) based on a scale that was distributed to participants.

Countries

United States

Participant flow

Participants by arm

ArmCount
Mindfulness-based Stress Reduction (MBSR) Intervention
Participants receiving a stress reduction plus sleep education intervention to improve sleep health
18
Total18

Baseline characteristics

CharacteristicMindfulness-based Stress Reduction (MBSR) Intervention
Age, Continuous29.89 years
STANDARD_DEVIATION 10.16
Education
Bachelor's degree
9 Participants
Education
Less than Bachelor's degree
2 Participants
Education
Professional degree (Master's, MD, PhD, law degree)
7 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
14 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race/Ethnicity, Customized
Race
Asian
2 Participants
Race/Ethnicity, Customized
Race
Black or African American
8 Participants
Race/Ethnicity, Customized
Race
Other
2 Participants
Race/Ethnicity, Customized
Race
White
6 Participants
Region of Enrollment
United States
18 Participants
Sex: Female, Male
Female
16 Participants
Sex: Female, Male
Male
2 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 18
other
Total, other adverse events
1 / 18
serious
Total, serious adverse events
0 / 18

Outcome results

Primary

Number of Participants With PSS Score Indicating High Stress

The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 27 to 40 are categorized as having high stress.

Time frame: Baseline, 4 weeks post-intervention

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Mindfulness-based Stress Reduction (MBSR) InterventionNumber of Participants With PSS Score Indicating High StressHigh stress at Baseline1 Participants
Mindfulness-based Stress Reduction (MBSR) InterventionNumber of Participants With PSS Score Indicating High StressHigh stress at 4 weeks post-intervention0 Participants
Primary

Number of Participants With PSS Score Indicating Low Stress

The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 0 to 13 are categorized as having low stress.

Time frame: Baseline, 4 weeks post-intervention

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Mindfulness-based Stress Reduction (MBSR) InterventionNumber of Participants With PSS Score Indicating Low StressLow stress at Baseline7 Participants
Mindfulness-based Stress Reduction (MBSR) InterventionNumber of Participants With PSS Score Indicating Low StressLow stress at 4 weeks post-intervention10 Participants
Primary

Number of Participants With PSS Score Indicating Moderate Stress

The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 14 to 26 are categorized as having moderate stress.

Time frame: Baseline, 4 weeks post-intervention

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Mindfulness-based Stress Reduction (MBSR) InterventionNumber of Participants With PSS Score Indicating Moderate StressModerate stress at Baseline10 Participants
Mindfulness-based Stress Reduction (MBSR) InterventionNumber of Participants With PSS Score Indicating Moderate StressModerate stress at 4 weeks post-intervention8 Participants
Primary

Perceived Stress Scale (PSS)

The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress.

Time frame: Baseline, 4 weeks post-intervention

ArmMeasureGroupValue (MEAN)Dispersion
Mindfulness-based Stress Reduction (MBSR) InterventionPerceived Stress Scale (PSS)Baseline15.72 score on a scaleStandard Deviation 7.73
Mindfulness-based Stress Reduction (MBSR) InterventionPerceived Stress Scale (PSS)4 weeks post-intervention13.44 score on a scaleStandard Deviation 7.47
Primary

Pittsburgh Sleep Quality Index (PSQI) Score

Global sleep quality was measured via the validated Pittsburgh Sleep Quality Index (PSQI). The PSQI is a self-rated questionnaire which assesses several dimensions of sleep including sleep quality, duration, and disturbances over a 1-month time interval. In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score which ranges from 0 to 21. Poor sleep quality is defined as a global score of 5 or greater.

Time frame: Baseline, 4 weeks post-intervention

ArmMeasureGroupValue (MEAN)Dispersion
Mindfulness-based Stress Reduction (MBSR) InterventionPittsburgh Sleep Quality Index (PSQI) ScoreBaseline7.22 score on a scaleStandard Deviation 2.96
Mindfulness-based Stress Reduction (MBSR) InterventionPittsburgh Sleep Quality Index (PSQI) Score4 weeks post-intervention5.00 score on a scaleStandard Deviation 2.2
Primary

Sleep Duration

Sleep duration was measured in hours and minutes using a sleep 7-day actigraphy (Philips Respironics Actiwatch Spectrum Plus) on the non-dominant wrist, and confirmed with daily sleep logs. Self-reported sleep duration was also measured.

Time frame: Baseline, 4 weeks post-intervention

Population: Some participants did not complete the 7-day actigraphy assessment.

ArmMeasureGroupValue (MEAN)Dispersion
Mindfulness-based Stress Reduction (MBSR) InterventionSleep Duration4 weeks post-intervention assessed by actigraphy6.18 hoursStandard Deviation 1.45
Mindfulness-based Stress Reduction (MBSR) InterventionSleep DurationBaseline assessed by self-report8.30 hoursStandard Deviation 1.33
Mindfulness-based Stress Reduction (MBSR) InterventionSleep DurationBaseline assessed by actigraphy6.19 hoursStandard Deviation 1.05
Mindfulness-based Stress Reduction (MBSR) InterventionSleep Duration4 weeks post-intervention assessed by self-report8.15 hoursStandard Deviation 1.82
Secondary

Blood Pressure

Blood pressure is the pressure of circulating blood on the walls of blood vessels and is measured in millimeters of mercury (mmHg). Three seated blood pressure measurements were made using an electronic sphygmomanometer. An average of the last two readings were used to assess systolic and diastolic blood pressure. Blood pressure values of less than 120 mmHg systolic and 80 mmHg diastolic are considered within the normal range.

Time frame: Baseline, 4 weeks post-intervention

ArmMeasureGroupValue (MEAN)Dispersion
Mindfulness-based Stress Reduction (MBSR) InterventionBlood PressureSystolic blood pressure at Baseline110.03 mmHgStandard Deviation 11.13
Mindfulness-based Stress Reduction (MBSR) InterventionBlood PressureSystolic blood pressure at 4 weeks post-intervention112.47 mmHgStandard Deviation 8.9
Mindfulness-based Stress Reduction (MBSR) InterventionBlood PressureDiastolic blood pressure at Baseline70.31 mmHgStandard Deviation 8.14
Mindfulness-based Stress Reduction (MBSR) InterventionBlood PressureDiastolic blood pressure at 4 weeks post-intervention71.06 mmHgStandard Deviation 6.99
Secondary

Body Mass Index (BMI)

Body mass index (BMI) is calculated as weight in kilograms (kg) divided by the square of the body height measured in meters (m). A BMI between 18.5 and 24.9 is considered to be normal weight. A BMI of 25-29.9 indicates overweight, while a BMI of 30 or more indicates obesity.

Time frame: Baseline, 4 weeks post-intervention

Population: One participant did not report weight at the 4 weeks post-intervention assessment.

ArmMeasureGroupValue (MEAN)Dispersion
Mindfulness-based Stress Reduction (MBSR) InterventionBody Mass Index (BMI)4 weeks post-assessment30.21 kg/m^2Standard Deviation 5.27
Mindfulness-based Stress Reduction (MBSR) InterventionBody Mass Index (BMI)Baseline29.93 kg/m^2Standard Deviation 5.22
Secondary

Weight

Participants provided their weight in pounds (lbs) based on a scale that was distributed to participants.

Time frame: Baseline, 4 weeks post-intervention

Population: One participant did not report weight at the 4 week post-intervention assessment.

ArmMeasureGroupValue (MEAN)Dispersion
Mindfulness-based Stress Reduction (MBSR) InterventionWeightBaseline180.64 poundsStandard Deviation 30
Mindfulness-based Stress Reduction (MBSR) InterventionWeight4 weeks post-intervention184.12 poundsStandard Deviation 29.77

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026